Skip to main content

Table 2 The development of SIRS and sepsis in the patient sample

From: Resuscitation with polymeric plasma substitutes is permissive for systemic inflammatory response syndrome and sepsis in multiply injured patients: a retrospective cohort study

  No colloids Colloids <5L/48h Colloids >5L/48h P value
SIRS admission 2.1 ± 1.2 2.2 ± 1.1 2.6 ± 1.1 <0.001
SIRS maximum 1.9 ± 1.4 2.4 ± 1.2 3.2 ± 0.9 <0.001*
SIRS day of maximum 2.2 ± 3.6 3.1 ± 4.4 5.9 ± 5.7 <0.001*
Sepsis (% of each group) 10 16 36 <0.001
Day of sepsis onset 7.9 ± 7.1 6.4 ± 5.4 9.1 ± 5.7 <0.001
Septic shock (% of each group) 3 2 9 <0.001
  1. Patients not receiving colloids vs. receiving colloids <5L/48h vs. colloids >5L/48h are compared. The sequence of SIRS development, sepsis, and the onset of sepsis and septic shock are shown in the investigated patient sample
  2. * ANOVA
  3. Kruskal–Wallis
  4. Significant if P < 0.05